Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging.

Chen W, Botvinick EH, Alavi A, Zhang Y, Yang S, Perini R, Zhuang H.

J Nucl Cardiol. 2008 Jan-Feb;15(1):73-9. doi: 10.1016/j.nuclcard.2007.09.027.

PMID:
18242482
2.

Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.

Suga K, Ogasawara N, Ariga M, Motoyama K, Hara A, Kume N, Matsunaga N.

Eur J Nucl Med. 2000 May;27(5):574-82.

PMID:
10853814
3.

Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.

van der Palen RL, Bulten BF, Mavinkurve-Groothuis AM, Bellersen L, van Laarhoven HW, Kapusta L, de Geus-Oei LF.

Nuklearmedizin. 2013 Dec 13;52(6):228-34. doi: 10.3413/Nukmed-0590-13-05. Epub 2013 Sep 18.

PMID:
24045423
4.

Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.

Kamiyoshi Y, Yazaki Y, Urushibata K, Koizumu T, Kasai H, Izawa A, Kinoshita O, Hongo M, Ikeda U.

Am J Cardiol. 2008 May 15;101(10):1482-6. doi: 10.1016/j.amjcard.2008.01.030. Epub 2008 Mar 26.

PMID:
18471462
5.

Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.

Jacobson AF, White S, Travin MI, Tseng C.

Nucl Med Commun. 2017 Feb;38(2):141-148. doi: 10.1097/MNM.0000000000000619.

PMID:
27861299
7.

Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.

Bengel FM, Barthel P, Matsunari I, Schmidt G, Schwaiger M.

J Nucl Med. 1999 Jun;40(6):904-10.

8.

Myocardial adrenergic innervation in patients with vasovagal syncope measured with 123I-MIBG uptake.

Lorincz I, Garai I, Varga E, Barta K, Simkó J, Szabó Z, Galuska L, Varga J.

Nucl Med Commun. 2009 Feb;30(2):134-9. doi: 10.1097/MNM.0b013e328319bfcc.

PMID:
19194211
9.

[Estimation of 123I-metaiodobenzylguanidine lung uptake in heart and lung diseases--with reference to lung uptake ratio and decrease of lung uptake].

Fujii T, Tanaka M, Yazaki Y, Kitabayashi H, Koizumi T, Sekiguchi M, Gomi T, Yano K, Itoh A.

Kaku Igaku. 1997 Nov;34(11):1005-11. Japanese.

PMID:
9455040
10.
11.

Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.

Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, Rascol O, Senard JM.

Mov Disord. 2003 Aug;18(8):890-7.

PMID:
12889078
12.

Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp.

Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, Sakajiri K, Tonami N.

Eur J Nucl Med. 2000 May;27(5):566-73.

PMID:
10853813
13.

Evaluation of regional cardiac sympathetic innervation in congenital long QT syndrome using 123I-MIBG scintigraphy.

Momose M, Kobayashi H, Kasanuki H, Kusakabe K, Tamaki A, Onishi S, Okawa T.

Nucl Med Commun. 1998 Oct;19(10):943-51.

PMID:
10234674
14.

Reduced lung uptake of iodine-123 metaiodobenzylguanidine in high-altitude pulmonary oedema.

Urushihata K, Koizumi T, Hanaoka M, Fujimoto K, Kubo K, Kobayashi T, Fujii T.

Respirology. 2008 Nov;13(6):897-902. doi: 10.1111/j.1440-1843.2008.01343.x. Epub 2008 Jul 24.

PMID:
18657059
15.

Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.

Simmons WW, Freeman MR, Grima EA, Hsia TW, Armstrong PW.

Circulation. 1994 Jun;89(6):2843-51.

PMID:
8205700
16.

Serial change in 123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus.

Nagamachi S, Jinnouchi S, Kurose T, Nishii R, Kawai K, Futami S, Tamura S, Matsukura S.

Ann Nucl Med. 2002 Feb;16(1):33-8.

PMID:
11922206
17.

Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.

Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, Gourgon R, Merlet P.

J Am Coll Cardiol. 1999 Mar;33(3):759-66.

18.

Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure.

Mu X, Hasegawa S, Yoshioka J, Maruyama A, Maruyama K, Paul AK, Yamaguchi H, Morozumi T, Hashimoto K, Kusuoka H, Nishimura T.

Ann Nucl Med. 2001 Oct;15(5):411-6.

PMID:
11758945
19.

No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.

Verberne HJ, de Bruin K, Habraken JB, Somsen GA, Eersels JL, Moet F, Booij J, van Eck-Smit BL.

Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):483-90. Epub 2006 Jan 20.

PMID:
16425032
20.

Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.

Isobe S, Izawa H, Iwase M, Nanasato M, Nonokawa M, Ando A, Ohshima S, Nagata K, Kato K, Nishizawa T, Murohara T, Yokota M.

J Nucl Med. 2005 Jun;46(6):909-16.

Supplemental Content

Support Center